Omega Dx (Asia) Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.20 Cr
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -6.68%
- Profit Growth 226.83%
- Ebitda -29.07%
- Net Worth 11.73%
- Total Assets 12.13%
About Omega Dx (Asia)
Omega Dx (Asia) Private Limited (ODAPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 12 July 2011 and has a history of 13 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Omegainvitro Diagnostics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prashant Maniar and Jagdeep Grewal serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909MH2011FTC219692
- Company No.
219692
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
12 Jul 2011
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Omega Dx (Asia)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Maniar  | Managing Director | 05-Aug-2011 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdeep Grewal  | Director | 01-Oct-2021 | Current |
Financial Performance of Omega Dx (Asia).
Omega Dx (Asia) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.68% decrease. The company also saw a substantial improvement in profitability, with a 226.83% increase in profit. The company's net worth Soared by an impressive increase of 11.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omega Dx (Asia)?
In 2023, Omega Dx (Asia) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Omega Dx (Asia)?
Omega Dx (Asia) has a workforce of 8 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omega Dx (Asia), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omega Dx (Asia)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
